4//SEC Filing
Bleil Lynn Dorsey 4
Accession 0000950170-25-083203
CIK 0001178879other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:48 PM ET
Size
6.9 KB
Accession
0000950170-25-083203
Insider Transaction Report
Form 4
Bleil Lynn Dorsey
Director
Transactions
- Award
Common Stock
2025-06-05+20,414→ 113,941 total - Award
Stock Options (right to buy)
2025-06-05+74,872→ 74,872 totalExercise: $5.96Exp: 2035-06-05→ Common Stock (74,872 underlying)
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001607309
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:48 PM ET
- Size
- 6.9 KB